I-131-Omburtamab
131I-Omburtamab (131I-Burtomab, 131I-8H9) is a monoclonal murine antibody, labeled [...]
I-131-Naxitamab
131I-Naxitamab (131I-3F8) is a murine antibody targeting GD2 (disialoganglioside), labeled [...]
I-131-CAM-H2
131I-CAM-H2 (131I-SGMIB anti-HER2-VHH1; 131I-SGMIB) is a targeted radionuclide therapeutic drug [...]
Ra-224-RadSpherin
224Ra-RadSpherin is a suspension of Radium-224 in degradable calcium carbonate [...]
Sn-117m-DTPA
117mSn-DTPA was studied in the years 1990s by Brookhaven National [...]
Lu-177-FAP-2286
177Lu-FAP-2286 (177Lu-3BP-2286) is a molecule from the FAPi family [...]
Ac-225-DOTATATE
225Ac-DOTATATE is the alpha-labeled analogue of 90Y- and 177Lu-DOTATATE. Several [...]
Ac-225-PSMA-617
225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]
Ac-225-Lintuzumab (Ac-225 Actimab-A™)
225Ac-Lintuzumab (225Ac-Actimab-A™, 225Ac-DOTA-huM195, 225Ac-DOTA-Lintuzumab) is the new name of the [...]
Ac-225-FPI-1434
225Ac-FPI-1434 (225Ac-FPX-01) is an alpha labeled antibody under development for [...]